Irregular Expression of Cellular Stress Response Markers in the Placenta of Women with Chronic Venous Disease

  1. García-Montero, Cielo
  2. Fraile-Martinez, Oscar
  3. Rodriguez-Martín, Sonia
  4. Funes Moñux, Rosa M.
  5. Saz, Jose V.
  6. Bravo, Coral
  7. De Leon-Luis, Juan A.
  8. Ruiz-Minaya, María
  9. Pekarek, Leonel
  10. Saez, Miguel A.
  11. García-Lledo, Alberto
  12. Alvarez-Mon, Melchor
  13. Bujan, Julia
  14. García-Honduvilla, Natalio
  15. Ortega, Miguel A.
Revista:
Antioxidants

ISSN: 2076-3921

Año de publicación: 2022

Volumen: 11

Número: 11

Páginas: 2277

Tipo: Artículo

DOI: 10.3390/ANTIOX11112277 GOOGLE SCHOLAR lock_openAcceso abierto editor

Otras publicaciones en: Antioxidants

Información de financiación

Financiadores

Referencias bibliográficas

  • (2016), Cardiovasc. J. Afr., 27, pp. 89, 10.5830/CVJA-2016-021
  • (2018), AACN Adv. Crit. Care, 29, pp. 273, 10.4037/aacnacc2018911
  • (2019), Clin. Res. Cardiol., 108, pp. 831, 10.1007/s00392-019-01441-x
  • (2013), Best Pract. Res. Clin. Obstet. Gynaecol., 27, pp. 791, 10.1016/j.bpobgyn.2013.08.001
  • (2017), Phlebolymphology, 4, pp. 160
  • (2018), J. Vasc. Surg. Venous Lymphat. Disord., 6, pp. 246, 10.1016/j.jvsv.2017.08.001
  • (2019), Adv. Ther., 36, pp. 13, 10.1007/s12325-019-0885-3
  • (2014), Phlebolymphology, 21, pp. 138
  • Ortega, M.A., Fraile-Martínez, O., García-Montero, C., Álvarez-Mon, M.A., Chaowen, C., Ruiz-Grande, F., Pekarek, L., Monserrat, J., Asúnsolo, A., and García-Honduvilla, N. (2021). Understanding Chronic Venous Disease: A Critical Overview of Its Pathophysiology and Medical Management. J. Clin. Med., 10.
  • (2008), J. Vasc. Surg., 47, pp. 183, 10.1016/j.jvs.2007.09.028
  • (2014), Int. Angiol., 33, pp. 212
  • (2014), Circulation, 130, pp. 333, 10.1161/CIRCULATIONAHA.113.006898
  • (2020), J. Vasc. Surg. Venous Lymphat. Disord., 8, pp. 342, 10.1016/j.jvsv.2019.12.075
  • (2021), Ann. Surg., 274, pp. 971, 10.1097/SLA.0000000000004631
  • (2019). Davies AH The Seriousness of Chronic Venous Disease: A Review of Real-World Evidence—PubMed. Adv. Ther., 36, 5–12.
  • (2018), Hum. Pathol., 77, pp. 45, 10.1016/j.humpath.2018.03.022
  • (2018), Histol. Histopathol., 33, pp. 567
  • Ortega, M.A., Saez, M.A., Fraile-Martínez, O., Asúnsolo, Á., Pekarek, L., Bravo, C., Coca, S., Sainz, F., Álvarez-Mon, M., and Buján, J. (2020). Increased angiogenesis and lymphangiogenesis in the placental villi of women with chronic venous disease during pregnancy. Int. J. Mol. Sci., 21.
  • Ortega, M.A., Gómez-Lahoz, A.M., Sánchez-Trujillo, L., Fraile-Martinez, O., García-Montero, C., Guijarro, L.G., Bravo, C., De Leon-Luis, J.A., Saz, J.V., and Bujan, J. (2022). Chronic Venous Disease during Pregnancy Causes a Systematic Increase in Maternal and Fetal Proinflammatory Markers. Int. J. Mol. Sci., 23.
  • He, F., Ru, X., and Wen, T. (2020). NRF2, a Transcription Factor for Stress Response and Beyond. Int. J. Mol. Sci., 21.
  • (2013), Annu. Rev. Pharmacol. Toxicol., 53, pp. 401, 10.1146/annurev-pharmtox-011112-140320
  • Ortega, M.A., Sánchez-Trujillo, L., Bravo, C., Fraile-Martinez, O., García-Montero, C., Saez, M.A., Alvarez-Mon, M.A., Sainz, F., Alvarez-Mon, M., and Bujan, J. (2021). Newborns of Mothers with Venous Disease during Pregnancy Show Increased Levels of Lipid Peroxidation and Markers of Oxidative Stress and Hypoxia in the Umbilical Cord. Antioxidants, 10.
  • (2020), J. Cell. Mol. Med., 24, pp. 4157, 10.1111/jcmm.15077
  • (2009), Biochem. J., 422, pp. 171, 10.1042/BJ20090471
  • (2004), Mol. Cell. Biol., 24, pp. 8477, 10.1128/MCB.24.19.8477-8486.2004
  • (2017), Oxid. Med. Cell. Longev., 2017, pp. 9237263
  • (2021), Am. J. Reprod. Immunol., 86, pp. e13496
  • (2006), Nat. Protoc., 1, pp. 581, 10.1038/nprot.2006.83
  • Ye, J., Coulouris, G., Zaretskaya, I., Cutcutache, I., Rozen, S., and Madden, T.L. (2012). Primer-BLAST: A tool to design target-specific primers for polymerase chain reaction. BMC Bioinform., 13.
  • (2004), Biotechniques, 37, pp. 226, 10.2144/04372ST03
  • (2020), Asian-Australas. J. Anim. Sci., 33, pp. 2021, 10.5713/ajas.20.0238
  • (2021), Front. Med., 8, pp. 577096, 10.3389/fmed.2021.577096
  • Ortega, M.A., Fraile-Martínez, O., García-Montero, C., Sáez, M.A., Álvarez-Mon, M.A., Torres-Carranza, D., Álvarez-Mon, M., Bujan, J., García-Honduvilla, N., and Bravo, C. (2022). The Pivotal Role of the Placenta in Normal and Pathological Pregnancies: A Focus on Preeclampsia, Fetal Growth Restriction, and Maternal Chronic Venous Disease. Cells, 11.
  • (2013), Immun. Ageing, 10, pp. 15, 10.1186/1742-4933-10-15
  • (2019), Annu. Rev. Pharmacol. Toxicol., 59, pp. 555, 10.1146/annurev-pharmtox-010818-021856
  • (2018), Antioxid. Redox Signal., 29, pp. 1727, 10.1089/ars.2017.7342
  • Saha, S., Buttari, B., Panieri, E., Profumo, E., and Saso, L. (2020). An overview of Nrf2 signaling pathway and its role in inflammation. Molecules, 25.
  • (2015), Clin. Sci., 129, pp. 989, 10.1042/CS20150436
  • (2016), Obstet. Med., 9, pp. 113, 10.1177/1753495X16648495
  • (2016), Clin. Exp. Hypertens., 38, pp. 225, 10.3109/10641963.2015.1081226
  • (2017), Biomark. Med., 11, pp. 295, 10.2217/bmm-2016-0250
  • (2012), J. Pregnancy, 2012, pp. 582748
  • (2017), Sci. Signal., 10, pp. eaam5711, 10.1126/scisignal.aam5711
  • (2020), Biochim. Biophys. Acta Mol. Basis Dis., 1866, pp. 165354, 10.1016/j.bbadis.2018.12.005
  • (2019), Oxid. Med. Cell. Longev., 2019, pp. 5164576
  • (2008), Investig. Ophthalmol. Vis. Sci., 49, pp. 1671, 10.1167/iovs.07-1099
  • (2021), Int. J. Med. Sci., 18, pp. 2814, 10.7150/ijms.58992
  • (2015), Free Radic. Biol. Med., 88, pp. 158, 10.1016/j.freeradbiomed.2015.05.017
  • (2012), Int. J. Med. Sci., 9, pp. 447, 10.7150/ijms.4593
  • (2016), Mol. Cell. Biol., 36, pp. 3100, 10.1128/MCB.00389-16
  • (2014), Free Radic. Biol. Med., 66, pp. 36, 10.1016/j.freeradbiomed.2013.02.008
  • (2019), Cancer Biol. Ther., 20, pp. 583, 10.1080/15384047.2018.1564562
  • Piergentili, R., Zaami, S., Cavaliere, A.F., Signore, F., Scambia, G., Mattei, A., Marinelli, E., Gulia, C., and Perelli, F. (2021). Non-Coding RNAs as Prognostic Markers for Endometrial Cancer. Int. J. Mol. Sci., 22.
  • (2015), Biomed Res. Int., 2015, pp. 293271
  • Cavaliere, A.F., Perelli, F., Zaami, S., Piergentili, R., Mattei, A., Vizzielli, G., Scambia, G., Straface, G., Restaino, S., and Signore, F. (2021). Towards Personalized Medicine: Non-Coding RNAs and Endometrial Cancer. Healthcare, 9.
  • Mundal, S.B., Rakner, J.J., Silva, G.B., Gierman, L.M., Austdal, M., Basnet, P., Elschot, M., Bakke, S.S., Ostrop, J., and Thomsen, L.C.V. (2022). Divergent Regulation of Decidual Oxidative-Stress Response by NRF2 and KEAP1 in Preeclampsia with and without Fetal Growth Restriction. Int. J. Mol. Sci., 23.
  • (2021), Front. Cardiovasc. Med., 8, pp. 654254, 10.3389/fcvm.2021.654254
  • (2015), Reproduction, 150, pp. 139, 10.1530/REP-15-0126
  • (2020), iScience, 23, pp. 101638, 10.1016/j.isci.2020.101638
  • (2020), Int. J. Med. Sci., 17, pp. 2790, 10.7150/ijms.49236
  • (2020), J. Matern. Fetal. Neonatal Med., 33, pp. 1946, 10.1080/14767058.2018.1531843
  • (2019), Biol. Reprod., 101, pp. 1018, 10.1093/biolre/ioz119
  • (2017), Adv. Biol. Regul., 65, pp. 5, 10.1016/j.jbior.2017.06.003
  • (2007), Mol. Cell. Biol., 27, pp. 3253, 10.1128/MCB.00015-07